Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: J Urol. 2012 Jan 15;187(3):862–867. doi: 10.1016/j.juro.2011.10.144

Fig 2.

Fig 2

Kaplan-Meier estimated progression-free survival curves (represented as percentage) by FISH assay results. FISH assay time points include the following: baseline (before initiation of intravesical immunotherapy with BCG), six weeks after treatment initiation, three months after treatment initiation, and six months after treatment initiation.